Question 1

How is a binding defect distinguished from a fusion defect?

Accepted Answer

By measuring attachment separately from merger. A mutant that fails to attach cannot fuse, so reporting reduced fusion tells you nothing until binding is quantified independently, usually by particle association at low temperature. Only when binding matches the parent does a fusion difference become attributable to the refolding step.

Question 2

Does a cell to cell fusion assay substitute for particle entry?

Accepted Answer

Not reliably. Surface expressed glycoprotein at high density on a cell membrane behaves differently from the sparse arrangement on a particle, and the trigger is delivered differently. The assay is useful and fast, but conclusions should be stated for the system tested and confirmed with particles before being generalised.

Question 3

How should the trigger condition be controlled?

Accepted Answer

By measuring it rather than assuming it. Endosomal acidity differs between cell types and shifts with treatment, so an assay that relies on it should include a direct measurement or a calibrated indicator. Where the trigger is proteolytic, protease availability in the chosen cell must be verified rather than inferred.

Question 4

What does resolving intermediates require?

Accepted Answer

Initiation synchronised across the population, usually by a rapid temperature or acidity jump, and detection fast enough to sample within the seconds the process occupies. Endpoint measurements report only whether merger happened. Single particle approaches trade throughput for the ability to see individual events resolve.

Question 5

How do timing experiments identify an inhibitor step?

Accepted Answer

By adding the agent at defined points relative to a synchronised trigger and asking when it stops working. An agent effective only before triggering acts on binding or on the initial change; one effective after triggering acts later. Reporting the time course rather than a single concentration makes the claim testable.

Question 6

Which readouts show that merger actually completed?

Accepted Answer

Content mixing rather than lipid mixing, since lipids can exchange through a stalled intermediate that never opens a pore. Running both distinguishes hemifusion from complete merger, and a system where the two disagree is often more informative about mechanism than one where they simply track together.

Microbiology

Microbiology

Research Frontiers in Viral Entry Mechanism and Membrane Fusion Dynamics